HIV-1 reservoir evolution in infants infected with clade C from Mozambique

Int J Infect Dis. 2023 Feb:127:129-136. doi: 10.1016/j.ijid.2022.11.042. Epub 2022 Dec 5.

Abstract

Background: The persistence of HIV-1-infected cells during antiretroviral therapy is well documented but may be modulated by early initiation of antiretroviral therapy in infants.

Methods: Here, we longitudinally analyzed the proviral landscape in nine infants with vertical HIV-1 infection from Mozambique over a median period of 24 months, using single-genome, near full-length, next-generation proviral sequencing.

Results: We observed a rapid decline in the frequency of intact proviruses, leading to a disproportional under-representation of intact HIV-1 sequences within the total number of HIV-1 DNA sequences after 12-24 months of therapy. In addition, proviral integration site profiling in one infant demonstrated clonal expansion of infected cells harboring intact proviruses and indicated that viral rebound was associated with an integration site profile dominated by intact proviruses integrated into genic and accessible chromatin locations.

Conclusion: Together, these results permit rare insight into the evolution of the HIV-1 reservoir in infants infected with HIV-1 and suggest that the rapid decline of intact proviruses, relative to defective proviruses, may be attributed to a higher vulnerability of genome-intact proviruses to antiviral immunity. Technologies to analyze combinations of intact proviral sequences and corresponding integration sites permit a high-resolution analysis of HIV-1 reservoir cells after early antiretroviral treatment initiation in infants.

Keywords: Evolution; HIV-1; Infants; Integration sites; Reservoir.

MeSH terms

  • CD4-Positive T-Lymphocytes
  • DNA, Viral / genetics
  • HIV Infections*
  • HIV Seropositivity*
  • HIV-1* / genetics
  • Humans
  • Infant
  • Mozambique / epidemiology
  • Proviruses / genetics
  • Viral Load

Substances

  • DNA, Viral